Reports Outline Follicular Lymphoma Study Results from Denise Wolff et al (AMCP Market Insights: Managed care approaches to bispecific antibodies with a focus on follicular lymphoma and diffuse large B-cell lymphoma): Oncology – Follicular Lymphoma

2025 OCT 03 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- A new study on Oncology - Follicular Lymphoma is now available. According to news reporting from Duluth, Minnesota, by NewsRx journalists, research stated, “Bispecific antibodies (bsAbs) are an emerging treatment modality particularly in hematologic malignancies such as the non-Hodgkin lymphomas follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL). Although bsAbs offer opportunities in the treatment of these conditions, they also present challenges, and additional longer-term data are needed to determine their optimal role.”

The news correspondents obtained a quote from the research, “To discuss managed care approaches to bsAbs with a focus on FL and DLBCL, AMCP Market Insights virtually convened an expert panel of managed care stakeholders in April 2025. Key insights from the discussion included that clinical efficacy is a primary consideration when evaluating the role of bsAbs in FL and DLBCL and that ongoing data collection is necessary for increased certainty in long-term outcomes, treatment comparisons, and real-world experience. Other insights related to treatment choice, site-of-care considerations, the evolving place of bsAbs in FL and DLBCL therapy, economic factors, and social determinants of health and equity.”

According to the news reporters, the research concluded: “Suggested payer best practices for bsAbs in FL and DLBCL also emerged from the discussion.”

This research has been peer-reviewed.

For more information on this research see: AMCP Market Insights: Managed care approaches to bispecific antibodies with a focus on follicular lymphoma and diffuse large B-cell lymphoma. Journal of Managed Care & Specialty Pharmacy, 2025;31. Journal of Managed Care & Specialty Pharmacy can be contacted at: Acad Managed Care Pharmacy, 100 N Pitt St, 400, Alexandria, VA 22314-3134, USA.

Our news journalists report that additional information may be obtained by contacting Denise Wolff, Denise & Co. LLC, Duluth, MN. Additional authors for this research include Bridget Flavin, Laura R. Bobolts, Tara Graff, Kirollos Hanna, Ryan Haumschild, Timothy Mok and Bhavesh Shah.

Publisher contact information for the Journal of Managed Care & Specialty Pharmacy is: Acad Managed Care Pharmacy, 100 N Pitt St, 400, Alexandria, VA 22314-3134, USA.

(Our reports deliver fact-based news of research and discoveries from around the world.)